Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

Sort By
Title Published Price Buy Now
European Pharmaceutical Directory 2012
By Asia Pacific InfoServ Pty Ltd
The market potential of the European biotechnology and pharmaceutical sector is enormous and business opportunities abound. However, unraveling the maze of who’s who, and who does what is a daunting task. Here’s the solution you’...
Feb 2012 $ 350
Asian Pharmaceutical Directory 2012
By Asia Pacific InfoServ Pty Ltd
Keep up-to-date with the Asian Pharmaceutical Industry and discover thousands of new business leads with this the top source of information on 10,000 pharmaceutical and biotechnology companies throughout Asia! The market potential of the As...
Feb 2012 $ 375
Middle East Pharmaceutical Directory 2012
By Asia Pacific InfoServ Pty Ltd
The market potential of the Middle East pharmaceutical and biotechnology sector is enormous and business opportunities abound. However, unraveling the maze of who’s who, and who does what is a daunting task. Here’s the solution you&rsq...
Feb 2012 $ 200
African Pharmaceutical Directory 2012
By Asia Pacific InfoServ Pty Ltd
The market potential of the African pharmaceutical and biotechnology sector is enormous and business opportunities abound. However, unraveling the maze of who’s who, and who does what is a daunting task. Here’s the solution you’v...
Feb 2012 $ 200
South and Central American Pharmaceutical Directory 2012
By Asia Pacific InfoServ Pty Ltd
Keep up-to-date with South & Central America’s Pharmaceutical Industry and discover thousands of new business leads with this the top source of information on pharmaceutical and biotechnology companies throughout Latin America....
Feb 2012 $ 200
European and USA Pharmaceutical Directory Directory 2012
By Asia Pacific InfoServ Pty Ltd
 The most comprehensive and accurate Directory of companies and executives in the pharmaceutical industry throughout Europe and the USA.API research into pharmaceutical companies and corporations Europe & USA...
Feb 2012 $ 325
Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016
By Renub Research
Hepatitis C virus drug market is experiencing a dramatic near-term growth, by crossing US$ 6 Billion in 2011 and is expected to be more than double of its current figure by 2015. This robust growth will be driven primarily by the launch of novel p...
Jan 2012 $ 975
Future Infectious Disease Testing Market: Growth Opportunities, Business Strategies, Market Entry Barriers and Risks
By Venture Planning Group
The report identifies the major opportunities for infectious disease testing instrumentation, reagent kits/test panels, consumables, as well as IT and auxiliary products; proposes design criteria for decentralized testing products; suggests altern...
Jan 2012 $ 950
Gauging the Biosimilar Effect: Will the Market Boom or Bust?
By Insight Pharma Reports
It was supposed to be the "epoch of biosimilars", or drugs that copied existing biologics but had the potential to be more cost-effective. Yet five years later, biosimilars have failed to reach their forecasted potential of $16.4 billion...
Jan 2012 $ 895
Biosimilar Drugs in Europe: Threat or Opportunity to Innovation?
By Insight Pharma Reports
Between now and 2019, a vast range of blockbuster drugs will go off patent, opening the floodgates in the EU to the biosimilars market. Already established there since 2006, biosimilars are set to be worth between $2.25 billion and $4.8 billion by...
Nov 2011 $ 595
US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition
By Koncept Analytics
Report SummaryPBM companies aim at merging retail pharmacy claims processing, formulary management and home delivery pharmacy services in order to develop and create an integrated product offering for payors. PBM is a...
Nov 2011 $ 800
OTC Drug Market in India 2011
By Netscribes
Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized...
Oct 2011 $ 795
Global Radiation Therapy Market Report: 2011 Edition
By Koncept Analytics
Report SummaryRadiation Therapy refers to the medical use of ionizing radiation as a part of cancer treatment to control malignant cells by destroying their DNA. Various types of radiations are generally used for the ...
Oct 2011 $ 800
Global Diabetes Market Report: 2011 Edition
By Koncept Analytics
Report SummaryDiabetes is a group of metabolic diseases in which a person has high blood sugar which is either due to the fact that insulin produced by the body is not enough or the body does not respond to the insuli...
Oct 2011 $ 800
Cardiovascular Pharmaceuticals Market in India 2011
By Netscribes
Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for cardiovascul...
Sep 2011 $ 795
Anti-Infective Pharmaceuticals Market in India 2011
By Netscribes
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs....
Sep 2011 $ 795
Global Ophthalmic Market: Focus on Diagnostics and Surgical Equipments
By Koncept Analytics
Report SummaryThe global ophthalmic market growth is driven by demographic trends, such as an increasing aged population and rising number of diabetic & ob...
Sep 2011 $ 800
Pharmaceuticals Brand PR: Developing Engaging Campaigns and Measuring ROI
By Insight Pharma Reports
The value of PR can seem immeasurable in brand positioning. Yet, in an age of budgetary juggling by marketing departments, the drive to scrutinize ROI is increasingly important. What' s more, as expectations on PR outcomes increase - in part d...
Sep 2011 $ 495
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
By Renub Research
Osteoporosis Market Overview Osteoporosis is often called the "silent disease" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading t...
Sep 2011 $ 950
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 - 2015)
By Renub Research
Schizophrenia - Market Overview Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bi...
Aug 2011 $ 850
Global Hepatitis C Virus (HCV) Market - An Analysis
By Koncept Analytics
Report Summary Hepatitis C virus (HCV) is commonly spread through blood from a person who has been infected through use of shared needles or equipment used to...
Aug 2011 $ 800
Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities
By Insight Pharma Reports
The field of kinase modulation is one of the most active in the biopharmaceutical industry. About 20 kinase inhibitors are approved for marketing in the United States and at least another 250 are in clinical evaluation. Kinases make up a veritable...
Aug 2011 $ 595
Pharma Marketing Excellence: Lessons From Experiences
By Insight Pharma Reports
Marketing excellence. Over the past five years, those two words have been the subject of hype and the focus of management attention. As the pharmaceutical industry struggles with market maturation and weakening product pipelines, marketing excelle...
Aug 2011 $ 595
The Impact of iPad on Pharma: A Primer
By Insight Pharma Reports
With the launch of Apple's iPad in April 2010, the way we use technology changed forever. Instant, portable and quick, the iPad is expected to sell 50 million units in 2011 alone.Its impact on Pharma is still being measured, but fo...
Jul 2011 $ 295
Alzheimer's Disease Patients & Market Worldwide, Future Scenario (2010 - 2015) & Drugs Analysis
By Renub Research
Overview Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, ...
Jun 2011 $ 950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy